You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma

  • Technology appraisal guidance
  • Reference number: TA319
  • Published:  23 July 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: final appraisal determination document

Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: final appraisal determination document Melanoma (previously untreated unresectable stage III or IV) - ipilimumab [ID74]: final appraisal determination document
12 June 2014
(424.93 Kb 3 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 12 June 2014

Back to top